ISPOR Europe 2025
9 - 12 November
-
Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions
Sep 9, 2025, 16:22 PM -
HTA Life-Cycle Concepts: The Need for HTA Bodies to Grow Beyond Their Traditional Scope
Sep 9, 2025, 16:22 PM -
Real-World–Based Cost-Effectiveness of Lipid-Lowering Therapies for ASCVD Patients With High CV Risk in Taiwan
Sep 9, 2025, 16:22 PM -
Budget Impact of Introducing Accuchek® Smartguide Real-Time Continuous Glucose Monitoring (RtCGM) Solution for Diabetes Management in Portugal
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in the Netherlands: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
Optimizing Colorectal Cancer Screening in the Czech Republic: Cost-Effectiveness of Lowering the Starting Age to 45 and Introducing an Upper Limit
Sep 9, 2025, 16:22 PM -
Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy
Sep 9, 2025, 16:22 PM -
Digital Health Technologies Assessment Based on Patient-Reported Outcome Measures (PROMs): Virtual Reality (VR) in the Treatment of Specific Phobias
Sep 9, 2025, 16:22 PM -
Single-Arm Trials and Reimbursement Decision Making in Europe: A Case Study in Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Imlifidase Idefirix® for Desensitization Treatment of Highly Sensitized Adult Kidney Transplant Patients in Ireland
Sep 9, 2025, 16:22 PM -
Improving Kidney Exchange Program Effectiveness and Equity by Using Allele and Eplet HLA Compatibility Technologies
Sep 9, 2025, 16:22 PM -
Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals
Sep 9, 2025, 16:22 PM -
Budget Impact of Anakinra in Turkiye: An Analysis From the Social Security Institution’s Perspective
Sep 9, 2025, 16:22 PM -
Deep Brain Stimulation: A Cost-Saving Treatment Option for Extreme Treatment-Refractory Obsessive-Compulsive Disorder in the UK?
Sep 9, 2025, 16:22 PM -
Detection of a Potential Pericarditis Safety Signal Associated With Azithromycin: Evidence From FAERS Disproportionality Analysis
Sep 9, 2025, 16:22 PM -
Optimizing Market Access in Europe: A Comparative Analysis of Submission Templates from the EU JCA and National HTA Bodies (HAS, G-BA, ZIN, DMC)
Sep 9, 2025, 16:22 PM